- Home
- SLQT vs PCRX Comparison
SLQT vs PCRX Comparison
Compare SLQT & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | PCRX |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.6M | 1.0B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | SLQT | PCRX |
|---|---|---|
| Price | $1.40 | $26.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $3.88 | ★ $32.86 |
| AVG Volume (30 Days) | ★ 864.0K | 723.2K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | ★ $1,563,142,000.00 | $716,791,000.00 |
| Revenue This Year | $13.00 | $6.24 |
| Revenue Next Year | $7.65 | $9.53 |
| P/E Ratio | ★ N/A | $55.78 |
| Revenue Growth | ★ 13.16 | 3.14 |
| 52 Week Low | $1.33 | $18.17 |
| 52 Week High | $6.86 | $27.64 |
Technical Indicators
Market Signals| Indicator | SLQT | PCRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.29 | 67.86 |
| Support Level | $1.38 | $25.17 |
| Resistance Level | $1.50 | $24.81 |
| Average True Range (ATR) | 0.08 | 0.96 |
| MACD | 0.02 | 0.26 |
| Stochastic Oscillator | 27.27 | 76.49 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.